Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating expenses:
Research and development	$ 9,427,667	$ 6,619,597
General and administrative	6,444,109	4,834,284
Depreciation	103,168	97,915
Loss from operations	(15,974,944)	(11,551,796)
Other income:
Interest income	114,257	85,302
Loss from operations before income taxes	(15,860,687)	(11,466,494)
Income tax benefit (expense)	1,675,381	(332,885)
Net loss	(14,185,306)	(11,799,379)
Deemed dividend arising from warrant exchange	(1,950,378)
Net loss attributable to common stockholders	$ (16,135,684)	$ (11,799,379)
Share information:
Net loss per share of common stock, basic and diluted (in dollars per share)	$ (0.30)	$ (1.76)
Weighted average shares outstanding, basic and diluted (in dollars per share)	$ 53,831,973	$ 6,706,509